FDA GLP-1 Compounding Crackdown 2026: What It Means for Patients Using Semaglutide/Tirzepatide
If you have been using compounded semaglutide or compounded tirzepatide as part of your weight loss treatment plan, recent FDA actions in 2026 may directly affect your access to these medications. The regulatory landscape around GLP-1 compounding 2026 has shifted significantly, and understanding what is happening now could save you from disruption down the road. […]